Innovative Medical Management Co.,Ltd. (SHE:002173)
China · Delayed Price · Currency is CNY 17.67
-0.66 (-3.60%)
Aug 24, 2026, 3:04 PM CST
SHE:002173 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Jan '22 Jan 1, 2022 |
Operating Revenue | 714.44 | 778.21 | 812.14 | 803.89 | 708.34 | 709.37 |
Other Revenue | 3.04 | 3.04 | 3.88 | 1.69 | 1.36 | 2.15 |
| 717.48 | 781.25 | 816.02 | 805.59 | 709.7 | 711.52 | |
Revenue Growth | -11.37% | -4.26% | 1.29% | 13.51% | -0.26% | -1.76% |
Cost of Revenue | 707.09 | 727.31 | 752.53 | 714 | 679.5 | 664.14 |
Gross Profit | 10.4 | 53.95 | 63.49 | 91.58 | 30.2 | 47.38 |
Selling, General & Admin | 107.11 | 111.05 | 114.89 | 118.02 | 118.82 | 122.12 |
Research & Development | 6.58 | 3.11 | - | - | - | - |
Other Operating Expenses | 12.41 | 10.64 | 11.11 | 9.68 | 3.7 | 6.52 |
Operating Expenses | 122.11 | 120.82 | 128.42 | 131.05 | 120.19 | 132.15 |
Operating Income | -111.72 | -66.88 | -64.93 | -39.47 | -89.99 | -84.78 |
Interest Expense | -3.82 | -3.82 | -4.09 | -3.65 | -3.35 | -6.06 |
Interest & Investment Income | 37.07 | 36.54 | 7.92 | 17.42 | 17.98 | 19.87 |
Currency Exchange Gain (Loss) | -0 | -0 | - | - | - | - |
Other Non Operating Income (Expenses) | -1.68 | -1.19 | -1.14 | -0.43 | -6.94 | 2.41 |
EBT Excluding Unusual Items | -80.14 | -35.34 | -62.24 | -26.13 | -82.3 | -68.55 |
Gain (Loss) on Sale of Investments | 5.66 | 4.77 | 1.98 | -1.84 | - | 9.04 |
Gain (Loss) on Sale of Assets | 0.03 | 0.02 | -1.42 | 1.06 | -1.16 | 0.06 |
Asset Writedown | -3.05 | -3.05 | -3.39 | -5.26 | -11.6 | -1.24 |
Legal Settlements | -3.31 | -3.31 | -34.89 | -3.17 | -15.59 | -40.59 |
Other Unusual Items | 8.02 | 8.02 | -0.67 | 0.38 | 35.36 | -1.79 |
Pretax Income | -72.78 | -28.88 | -100.63 | -34.96 | -75.28 | -103.08 |
Income Tax Expense | 6.98 | 7.37 | -6.65 | -0.68 | -1.69 | 0.27 |
Earnings From Continuing Operations | -79.76 | -36.26 | -93.99 | -34.29 | -73.6 | -103.36 |
Net Income to Company | -79.76 | -36.26 | -93.99 | -34.29 | -73.6 | -103.36 |
Minority Interest in Earnings | 3.44 | 1.4 | 0.03 | 0 | 0.17 | -0.11 |
Net Income | -76.32 | -34.85 | -93.95 | -34.29 | -73.42 | -103.46 |
Net Income to Common | -76.32 | -34.85 | -93.95 | -34.29 | -73.42 | -103.46 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 466 | 436 | 447 | 429 | 445 | 450 |
Shares Outstanding (Diluted) | 466 | 436 | 447 | 429 | 445 | 450 |
Shares Change | 6.89% | -2.62% | 4.39% | -3.77% | -0.99% | -1.31% |
EPS (Basic) | -0.16 | -0.08 | -0.21 | -0.08 | -0.16 | -0.23 |
EPS (Diluted) | -0.16 | -0.08 | -0.21 | -0.08 | -0.16 | -0.23 |
EPS Growth | - | - | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Jan '22 Jan 1, 2022 |
Free Cash Flow | -57.91 | -8.59 | -54.3 | -85.21 | -147.62 | -67.35 |
Free Cash Flow Per Share | -0.12 | -0.02 | -0.12 | -0.20 | -0.33 | -0.15 |
Gross Margin | 1.45% | 6.91% | 7.78% | 11.37% | 4.26% | 6.66% |
Operating Margin | -15.57% | -8.56% | -7.96% | -4.90% | -12.68% | -11.92% |
Profit Margin | -10.64% | -4.46% | -11.51% | -4.26% | -10.35% | -14.54% |
Free Cash Flow Margin | -8.07% | -1.10% | -6.65% | -10.58% | -20.80% | -9.47% |
EBITDA | -26.32 | 16.14 | 27.37 | 56.87 | 8.77 | 30.91 |
EBITDA Margin | -3.67% | 2.07% | 3.35% | 7.06% | 1.23% | 4.34% |
D&A For EBITDA | 85.4 | 83.01 | 92.3 | 96.34 | 98.76 | 115.69 |
EBIT | -111.72 | -66.88 | -64.93 | -39.47 | -89.99 | -84.78 |
EBIT Margin | -15.57% | -8.56% | -7.96% | -4.90% | -12.68% | -11.92% |
Revenue as Reported | 781.25 | 781.25 | 816.02 | 805.59 | 709.7 | 711.52 |